EXICURE, INC. Increase (Decrease) in Contract with Customer, Liability
EXICURE, INC. (XCUR) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2024-06-06
- EXICURE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-12-31 was $0.00.
- EXICURE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-09-30 was $0.00.
- EXICURE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-06-30 was $0.00.
- EXICURE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-03-31 was $0.00.
- EXICURE, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $0.00.
- EXICURE, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$28.83M, a 240.73% decline from fiscal 2021.
- EXICURE, INC. increase (decrease) in contract with customer, liability for fiscal 2021 was $20.48M.
- EXICURE, INC. increase (decrease) in contract with customer, liability for fiscal 2020 was -$16.49M, a 166.40% decline from fiscal 2019.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 10-K · filed 2024-06-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 10-Q · filed 2024-05-16 | -$21.77M derived: sum of 4 quarters · filed 2024-06-06 |
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | $0.00 10-Q/A · filed 2024-06-06 | -$21.77M derived: sum of 3 quarters · filed 2024-06-06 | -$23.79M derived: sum of 4 quarters · filed 2024-06-06 |
| 2023-03-31 | $0.00 10-Q/A · filed 2024-06-06 | -$21.77M derived: sum of 2 quarters · filed 2024-06-06 | -$23.79M derived: sum of 3 quarters · filed 2024-06-06 | -$26.26M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-12-31 | -$21.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | -$23.79M derived: sum of 2 quarters · filed 2024-06-06 | -$26.26M derived: sum of 3 quarters · filed 2024-06-06 | -$28.83M 10-K · filed 2024-06-06 |
| 2022-09-30 | -$2.02M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | -$4.49M derived: sum of 2 quarters · filed 2024-06-06 | -$7.05M 10-Q · filed 2024-05-16 | -$9.17M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | -$2.47M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | -$5.04M 10-Q/A · filed 2024-06-06 | -$7.15M derived: sum of 3 quarters · filed 2024-06-06 | $16.52M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | -$2.56M 10-Q/A · filed 2024-06-06 | -$4.68M derived: sum of 2 quarters · filed 2024-06-06 | $18.99M derived: sum of 3 quarters · filed 2024-06-06 | $18.91M derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $21.56M derived: sum of 2 quarters · filed 2023-03-27 | $21.48M derived: sum of 3 quarters · filed 2023-03-27 | $20.48M 10-K · filed 2023-03-27 |
| 2021-09-30 | $23.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $23.60M derived: sum of 2 quarters · filed 2022-11-14 | $22.60M 10-Q · filed 2022-11-14 | $22.47M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$1.08M 10-Q · filed 2022-08-15 | -$1.21M derived: sum of 3 quarters · filed 2022-08-15 | -$3.61M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$997.00K 10-Q · filed 2022-05-16 | -$1.13M derived: sum of 2 quarters · filed 2022-05-16 | -$3.53M derived: sum of 3 quarters · filed 2022-05-16 | -$8.37M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$2.54M derived: sum of 2 quarters · filed 2022-03-25 | -$7.37M derived: sum of 3 quarters · filed 2022-03-25 | -$16.49M 10-K · filed 2022-03-25 |
| 2020-09-30 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | -$7.24M derived: sum of 2 quarters · filed 2021-11-19 | -$16.35M 10-Q · filed 2021-11-19 | $8.46M derived: sum of 4 quarters · filed 2021-11-19 |
| 2020-06-30 | -$4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$13.95M 10-Q · filed 2021-08-12 | $10.87M derived: sum of 3 quarters · filed 2021-08-12 | $10.34M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$9.12M 10-Q · filed 2021-05-12 | $15.70M derived: sum of 2 quarters · filed 2021-05-12 | $15.17M derived: sum of 3 quarters · filed 2021-05-12 | $14.74M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $24.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $24.29M derived: sum of 2 quarters · filed 2021-03-11 | $23.85M derived: sum of 3 quarters · filed 2021-03-11 | $24.83M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$527.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$961.00K derived: sum of 2 quarters · filed 2020-11-12 | $14.00K 10-Q · filed 2020-11-12 | $14.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $541.00K 10-Q · filed 2020-08-12 | $541.00K derived: sum of 3 quarters · filed 2020-08-12 | $541.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $975.00K 10-Q · filed 2020-05-14 | $975.00K derived: sum of 2 quarters · filed 2020-05-14 | $975.00K derived: sum of 3 quarters · filed 2020-05-14 | $975.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | $0.00 derived: sum of 3 quarters · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | -$2.07M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | -$2.07M derived: sum of 3 quarters · filed 2019-09-23 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | -$2.07M derived: sum of 2 quarters · filed 2019-09-23 | ||
| 2017-12-31 | -$2.07M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | -$8.28M 10-K/A · filed 2019-09-23 | ||
| 2017-09-30 | -$6.21M 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |